THOUSAND OAKS, Calif., September 7, 2006 -- Amgen (NASDAQ: AMGN) today announced the launch of the Aranesp® (darbepoetin alfa) prefilled SureClick TM autoinjector for patients with ...
This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...
Patients with chemotherapy-induced anemia and anemia associated with chronic kidney disease (CKD) will now have access to Amgen's Aranesp, which is a prefilled autoinjector. The product will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results